332.50EUR-3.20%Mkt Cap: 3.03B $P/E: 18.471d ago
Virbac SA manufactures and sells a range of products and services for companion and farm animals in Europe, North America, Latin America, East Asia, India, Africa, the Middle East, the United States, Brazil, and the Paci…
Industry Peers
Drug Manufacturers - Generalvs Drug Manufacturers - General
P/E
Cheaper
P/B
Cheaper
Div Yield
Higher
1M Perf
Higher
$1.07TUSDP/E 42.6
$611.36BUSDP/E 29.4
$444.21BUSDP/E 123.9
$308.01BUSDP/E 21.1
$317.37BUSDP/E 36.2
$281.52BUSDP/E 22.5
$275.65BUSDP/E 22.4
$269.91BUSDP/E 28.1
$237.69BUSDP/E 28.0
$202.85BUSDP/E 11.5
$195.44BUSDP/E 25.2
$156.86BUSDP/E 17.2
$137.24BUSDP/E 18.4
$117.66BUSDP/E 16.1
$97.68BUSDP/E 19.0
$86.27BUSDP/E 14.0
$51.69BUSD
$31.90BUSDP/E 23.3
MRV
Marvell Technology, Inc.$30.93BUSDP/E 11.7
$11.35BUSDP/E 22.7
$11.02BUSDP/E 19.1
$10.98BUSDP/E 19.1
$6.60BUSDP/E 14.6
$3.56BUSDP/E 14.6
$54.86MUSD
$39.77MUSD
ELXR
Elixxer Ltd.$9.51MUSD
PHOO
Photocure ASA—
FLXN
Horizon Flexible Income ETF—P/E 27.2
CELG-RI
Bristol-Myers Squibb Company Ce—
ROSE
DocMorris AG—
Indicators:|
Key Statistics
Company
Market Cap3.03B $
Enterprise Value3.21B $
Revenue (TTM)1.59B $
Gross Profit1.06B $
Net Income (TTM)164.01M $
Revenue/Share190.06 USD
Last Price332.50 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees6.4K
CountryFR
SectorHealthcare
IndustryDrug Manufacturers - General
ISINFR0000031577
Valuation
P/E (Trailing)18.47
P/E (Forward)14.75
PEG3.27
EV/EBITDA10.64
EV/Revenue2.01
P/S1.90
P/B2.48
EPS (TTM)18.00
EPS (Forward)22.54
52W Range
296.0039% of range389.50
52W High389.50 EUR
52W Low296.00 EUR
Profitability
Gross Margin66.58%
Oper. Margin13.47%
EBITDA Margin18.91%
Profit Margin10.30%
ROE13.41%
ROA7.88%
Growth
Revenue Growth4.60%
Earnings Growth35.20%
Cash Flow & Leverage
Operating CF216.29M $
CapEx (TTM)111.02M $
FCF Margin8.57%
FCF Yield4.50%
Net Debt177.69M $
Net Debt/EBITDA0.59
Balance Sheet
Debt/Equity0.26
Current Ratio1.53
Quick Ratio0.77
Book Value/Sh134.31 EUR
Cash/Share15.06 EUR
Dividends
Fwd Div Rate1.450 EUR
Trail. Div Rate1.450 EUR
Div. Yield0.43%
5Y Avg Yield0.38%
Payout Ratio8.06%
Ex-Div DateJul 2, 2026
Pay Date—
Splits
Last Split4:1
Split DateJul 30, 2002
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)412.88 EUR
Upside (mean)+24.2%
Target Range368.00 EUR – 440.00 EUR
€368.00+24.2% to mean€440.00
# Analysts8
Ownership
Shares Out.8.38M
Float4.13M
Insiders50.82%
Institutions25.40%
Technical
SMA 50354.19 (-6.1%)
SMA 200350.36 (-5.1%)
Beta0.76
S&P 52W Chg20.05%
Avg Vol (30d)2.55K
Avg Vol (10d)4.14K
Technical Indicators
RSI (14)40.1
MACD-4.3585
MACD Signal-4.5985
MACD Hist.+0.2399
BB Upper352.35 EUR
BB Middle341.45 EUR
BB Lower330.55 EUR
BB Width6.38%
ATR (14)8.160 EUR
Vol Ratio (20d)3.11x